Showing results (601-610 of 669) with videos related to

Sort By:
Pageof 67
Hemasphere|February 26, 2026
Outcomes of second-line axicabtagene ciloleucel for large B-cell lymphoma in the UKAndrea Kuhnl, Amy A Kirkwood, Michael Northend, et al.
Hemasphere|February 23, 2026
How I manage luspatercept in transfusion-dependent beta-thalassemiaDaniele Lello Panzieri, Natalia Scaramellini, Simona Leoni, et al.
Hemasphere|March 12, 2026
Correction to "Genetic evolution and relapse-associated mutations in adult T-cell acute lymphoblastic leukemia patients treated in PETHEMA trials"
Hemasphere|December 23, 2021
Sustained but Declining Humoral Immunity Against SARS-CoV-2 at 9 Months Postvaccination With BNT162b2: A Prospective Evaluation in 309 Healthy IndividualsEvangelos Terpos, Vangelis Karalis, Ioannis Ntanasis-Stathopoulos, et al.
Hemasphere|February 16, 2026
Outcomes of therapy-related non-core binding factor acute myeloid leukemia with venetoclax-based therapiesJayastu Senapati, Jennifer Croden, Guillermo Garcia-Manero, et al.
Hemasphere|February 9, 2026
Additive effect of multiple genetic variants in SEC23B and PIEZO1 on iron metabolism dyshomeostasis in hereditary anemiasAntonella Nostroso, Roberta Marra, Barbara Eleni Rosato, et al.
Hemasphere|January 21, 2026
Biological heterogeneity in adult IRF4-rearranged large B-cell lymphoma: Stratification by age and anatomical siteYuxiu Zhang, Anqi Li, Yimin Li, et al.
Hemasphere|January 14, 2026
Drivers of clinical resistance to venetoclax and hypomethylating agents in acute myeloid leukemia and strategies for improving efficacyIda Vänttinen, Joseph Saad, Tanja Ruokoranta, et al.
Hemasphere|January 12, 2026
Hypomorphic ATP11c is a novel regulator of decreased efficacy of transfused red blood cells in humans and miceJames C Zimring, Ariel M Hay, Monika Dzieciatkowska, et al.
Hemasphere|January 14, 2026
Application of machine learning in the diagnostic work-up of telomere biology disordersErika Massaccesi, Luca Arcuri, Giacomo Cavalca, et al.
Pageof 67